rating: 0+x
Sample of SCP-XXXX

Item #: SCP-XXXX

Object Class: Safe

Special Containment Procedures: All instances of SCP-XXXX are to be contained in a locked and labeled metal box at Storage Site 25. Task Force Xi-25 (Penny Candy) is to monitor all confectionary vendors within 25 kilometers of ████, Poland for any possible instances of SCP-XXXX. Access to SCP-XXXX requires level three clearance. Testing of SCP-XXXX is to be done only on D-class personnel in a secure observation room.

Description: SCP-XXXX are spherical candies three centimeters in diameter, with a design resembling the human eyeball. Testing has shown that the chemical composition of SCP-XXXX resembles that of gumballs, with several unidentifiable trace ingredients. Currently, there are ██ instances of SCP-XXXX in containment, with an undetermined amount theorized to be still in circulation.

SCP-XXXX's anomalous properties manifest if an individual candy is chewed by a human being for more than fifteen seconds. The subject will begin to report a pain in his or her eyes, as well as an itching feeling. After approximately three minutes, boils will form sporadically on most parts of the subject's body, including the inside of the mouth and anus. The boils will grow rapidly in size, and contact with the boils causes extreme pain in the subject. An hour after the original effects manifest, the boils will stop growing, and are approximately 2.5 centimeters wide at this point. At this point, vague, eye-like shapes will spontaneously form below the surface of the boils. The boils will change to resemble skin.

Shallow furrows will begin to bisect the boils, and hairs will form along the furrows. After a boil has been fully bisected, it will open, revealing a human eyeball, unconnected to any optic nerves. Eyes formed by SCP-XXXX's anomalous effects will match the subject's DNA, and are identical to the subject's eyes. However, subjects do not report being able to see through them. The eyes appear to look about and blink randomly, and cannot be controlled by the subject. Harming the eyes damages the subject's original eyes to the same extent. If the subject lacks eyes, eyes will grow in their eye sockets. However, it has been shown that the subject will still not be able to see out of these eyes. The eyes do not seem to notice damage, and do not always blink if threatened.

The eyes will remain on the subject's body for up to three days. As time passes, they will begin to protrude more, up to approximately half of the eye being above the skin. After approximately two days, most movements will cause the subject pain, due to contact or damage with the eyes on the body. The subject tends to damage the eyes at this point, especially ones on the bottom of the feet or the back. After three days have passed, the eyes will become firm, and stop blinking. Five minutes after they have stiffened, the eyes will begin to extract themselves from the subject's skin, causing lesions and bleeding. At this point, damage to the eyes no longer affects the subject. Once the eyes are completely separate from the subject, they are to be considered new instances of SCP-XXXX.

Addendum: SCP-XXXX was discovered in the storeroom of a pharmacy in ████, Poland. The pharmacist was discovered in a side room, with a large amount of eyeless corpses, some showing signs of SCP-XXXX's effects. The pharmacist was killed in the attempt to apprehend him. The pharmacist's diary was recovered.

Foundation agents were sent to investigate after reports of children in the area growing multiple eyes. Amnesiacs were administered to the unaffected residents. The children were taken into Foundation custody, under the pretext of infectious disease. During the observation and establishment of SCP-XXXX's effects, all of the children expired. Dissection of the children revealed that several eyes had also grown on the internal organs, especially the outer layer of the stomach. It is not known how the eyes were able to grow there without causing pain to the subject.

Unless otherwise stated, the content of this page is licensed under Creative Commons Attribution-ShareAlike 3.0 License